Akoya biosciences inc AKYA.US 總覽分析

美股醫療保健
(AKYA 無簡報檔)

AKYA 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分中等,已經有部位可以持續持有,若想建立新部位可以等待價值評分轉變為4分以上、股利提升為2分以上

AKYA 近期報酬表現

-3.51%

Akoya biosciences inc

0.38%

同產業平均

-0.07%

S&P500

與 AKYA 同產業的標的表現

  • ENOV Enovis corp
    價值 1 分趨勢 2 分波段 2 分籌碼 3 分股利 1 分
    查看更多

AKYA 公司資訊

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. It offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays.

AKYA 股價